Kim BY - Search Results

1

Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors.

George J, Chen Y, Abdelfattah N, Yamamoto K, Gallup TD, Adamson SI, Rybinski B, Srivastava A, Kumar P, Lee MG, Baskin DS, Jiang W, Choi JM, Flavahan W, Chuang JH, Kim BY, Xu J, Jung SY, Yun K. George J, et al. Among authors: kim by. Cancer Res Commun. 2022 Jun;2(6):402-416. doi: 10.1158/2767-9764.crc-22-0124. Epub 2022 Jun 6. Cancer Res Commun. 2022. PMID: 36688010 Free PMC article.

2

Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.

Liu J, Jiang W, Mao K, An Y, Su F, Kim BY, Liu Q, Jacobs LK. Liu J, et al. Among authors: kim by. Breast Cancer Res Treat. 2015 Apr;150(2):439-45. doi: 10.1007/s10549-015-3315-5. Epub 2015 Mar 13. Breast Cancer Res Treat. 2015. PMID: 25764167 Free PMC article.

3

Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.

Jiang W, Huang Y, An Y, Kim BY. Jiang W, et al. Among authors: kim by. ACS Nano. 2015 Sep 22;9(9):8689-96. doi: 10.1021/acsnano.5b02028. Epub 2015 Jul 31. ACS Nano. 2015. PMID: 26212564

4

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.

Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim BY, Liu Q, Jacobs LK. Liu J, et al. Among authors: kim by. Oncotarget. 2016 Apr 26;7(17):24848-59. doi: 10.18632/oncotarget.6664. Oncotarget. 2016. PMID: 26709538 Free PMC article.

5

Breaking Down the Barriers to Precision Cancer Nanomedicine.

von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BYS. von Roemeling C, et al. Trends Biotechnol. 2017 Feb;35(2):159-171. doi: 10.1016/j.tibtech.2016.07.006. Epub 2016 Aug 1. Trends Biotechnol. 2017. PMID: 27492049 Review.

6

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Yuan H, et al. Nat Nanotechnol. 2017 Aug;12(8):763-769. doi: 10.1038/nnano.2017.69. Epub 2017 May 1. Nat Nanotechnol. 2017. PMID: 28459470

7

Immune Priming of the Tumor Microenvironment by Radiation.

Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Jiang W, et al. Trends Cancer. 2016 Nov;2(11):638-645. doi: 10.1016/j.trecan.2016.09.007. Epub 2016 Oct 15. Trends Cancer. 2016. PMID: 28741502 Review.

8

S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.

Chow KH, Park HJ, George J, Yamamoto K, Gallup AD, Graber JH, Chen Y, Jiang W, Steindler DA, Neilson EG, Kim BYS, Yun K. Chow KH, et al. Cancer Res. 2017 Oct 1;77(19):5360-5373. doi: 10.1158/0008-5472.CAN-17-1294. Epub 2017 Aug 14. Cancer Res. 2017. PMID: 28807938 Free PMC article.

9

Improving immune-vascular crosstalk for cancer immunotherapy.

Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W. Huang Y, et al. Nat Rev Immunol. 2018 Mar;18(3):195-203. doi: 10.1038/nri.2017.145. Epub 2018 Jan 15. Nat Rev Immunol. 2018. PMID: 29332937 Free PMC article. Review.

10

Immunomodulating Nanomedicine for Cancer Therapy.

Liu Z, Jiang W, Nam J, Moon JJ, Kim BYS. Liu Z, et al. Nano Lett. 2018 Nov 14;18(11):6655-6659. doi: 10.1021/acs.nanolett.8b02340. Epub 2018 Sep 10. Nano Lett. 2018. PMID: 30185039 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,318 results

Search Page